Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Conatus Pharmaceuticals Inc. (CNAT)

« Back to company index

CNAT Chatter Timeline

Stock Ticker for CNAT

Most Active Tweeters for CNAT

UserTweets
@TraderNickPA 9
@tymax521 8
@thefinreviewer 8
@biotchart 7
@jsksrs 6

Recent Tweets for CNAT

PulsetradesCom @PulsetradesCom
$CNAT is done? https://t.co/prIvqxqsU5 NASH Failed and Pipeline is dead https://t.co/Bcr8GUeD9J
March 21st 2019, 11:03pm
Biotrade_alert @Biotrade_alert
$CNAT.. next catalyst 2Q 2019. Still has $40 million cash (December, 2019). I will add more share tomorrow. Not goi… https://t.co/uRRyY0zqgM
March 21st 2019, 10:03pm
Janijasoos @Janijasoos
RT @adamfeuerstein: $CNAT CEO: "The emricasan study in NASH failed but we will push ahead anyway because in six months, no one will remembe…
March 21st 2019, 10:03pm
BiotechMoney18 @BiotechMoney18
$CNAT -50.86% after hours. Fail NASH data
March 21st 2019, 9:03pm
EMcCallister01 @EMcCallister01
RT @BioCentury: Conatus sinks after NASH therapy misses fibrosis endpoint $CNAT https://t.co/0iUgXnUrDB
March 21st 2019, 8:03pm
BioCentury @BioCentury
Conatus sinks after NASH therapy misses fibrosis endpoint $CNAT https://t.co/0iUgXnUrDB
March 21st 2019, 8:03pm
DrTranBioSci @DrTranBioSci
IBI Market Moving Report: Assessing Conatus' ENCORE-NF Outcomes $CNAT $NVS https://t.co/1awyq2NhuI
March 21st 2019, 7:03pm
ThibLec @ThibLec
RT @nashbiotechs: $CNAT. infortunate failure of phase 2b. ENCORE-NF Emricasan removed from the active NASHBIOTECHS compound list. New Mark…
March 21st 2019, 7:03pm
Zackfoot @Zackfoot
Can someone explain to me why $CNAT management has any reason to believe that with a #FAIL for Emricasan in NASH so… https://t.co/IWZPzQ8L3a
March 21st 2019, 7:03pm
lblegend33 @lblegend33
@QueenBioInvest @jsksrs $cnat ouch
March 21st 2019, 7:03pm
LTRR2000 @LTRR2000
RT @trading_mz: *CONATUS SINKS 43% AFTER NASH FIBROSIS STUDY FAILS TO MEET GOAL $CNAT
March 21st 2019, 6:03pm
MarketChmln @MarketChmln
$CNAT declines in after hours trading. See the latest news. https://t.co/3FeCcN3sHp https://t.co/AOeMQzqypL
March 21st 2019, 6:03pm
4thQuarterCap @4thQuarterCap
My $CNAT lotto not going so well. Two more readouts in mid 19. Drug seems to be a flop. Currently down -74% now.
March 21st 2019, 6:03pm
nashbiotechs @nashbiotechs
$CNAT. infortunate failure of phase 2b. ENCORE-NF Emricasan removed from the active NASHBIOTECHS compound list. Ne… https://t.co/J4t4eUuO6j
March 21st 2019, 6:03pm
JuiCheng4 @JuiCheng4
@agamemnus_dev @semodough Buy $CNAT!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
March 21st 2019, 6:03pm
stocktrader8000 @stocktrader8000
$CNAT Great trading here under $2.
March 21st 2019, 5:03pm
saar_eldar @saar_eldar
$CNAT looking to bust 1.50
March 21st 2019, 5:03pm
JohnLBair1 @JohnLBair1
$CNAT had a nice little bounce, shorts made a killing.The risks of #Bio #Bios #BioTech https://t.co/lUqUwtPw3r
March 21st 2019, 5:03pm
TheBull_Stocks @TheBull_Stocks
$CNAT$1.49 #Bouncer https://t.co/0LDkHI5fJD
March 21st 2019, 5:03pm
MONSTAMONEYMOVA @MONSTAMONEYMOVA
$CNAT 1.43 +.20 https://t.co/msy8DNePAd
March 21st 2019, 5:03pm
chriskemprealty @chriskemprealty
$CNAT What a POS company and CEO. Do Not Trade this pile of garbage. Horrible product.
March 21st 2019, 5:03pm
TTOON_STOCKS @TTOON_STOCKS
$CNAT $1.30 -53% big drop Afterhour on top-line results from the companys Phase 2b ENCORE-NF clinical trial in pati… https://t.co/9HHLfscMyo
March 21st 2019, 5:03pm
MONSTAMONEYMOVA @MONSTAMONEYMOVA
$CNAT 1.33 +.10 https://t.co/XgZpQExG8y
March 21st 2019, 5:03pm
Ultra_Calls @Ultra_Calls
$CNAT Reversal AH
March 21st 2019, 5:03pm
pawcio2009 @pawcio2009
Added more fish oil stock today (18.64), sold 2/3 $ndra with data imminent, also holding some lotto $cnat which is… https://t.co/pqHtmjDH2l
March 21st 2019, 5:03pm
MONSTAMONEYMOVA @MONSTAMONEYMOVA
$CNAT 1.23 Thank You https://t.co/ZTMj6X212s
March 21st 2019, 5:03pm
stocktrader8000 @stocktrader8000
$CNAT Bought here. Note: I think the media companies who wrote those headlines should cover everyone's losses, but… https://t.co/Q46w6Wo9I4
March 21st 2019, 4:03pm
TraderNickPA @TraderNickPA
I got crushed. $CNAT
March 21st 2019, 4:03pm
RoccoLefkowitz @RoccoLefkowitz
Think I’ll give $CNAT a little more time to settle before buying it back this time. Under 1 seems likely.
March 21st 2019, 4:03pm
timmyotoole23 @timmyotoole23
RT @TheIpHawk: $CNAT going to make for some great @BagholderQuotes material
March 21st 2019, 4:03pm
Kevin_W81 @Kevin_W81
$CNAT -50% after P2 data fail ?~$30M cash end of March 2019 ?Low float ?Another data coming by June 2019 Dead mea… https://t.co/fMQj7ZcXhr
March 21st 2019, 4:03pm
TheIpHawk @TheIpHawk
$CNAT going to make for some great @BagholderQuotes material
March 21st 2019, 4:03pm
fobmanny @fobmanny
$CNAT .... com'on man!!! https://t.co/7gNY7u9y2R
March 21st 2019, 4:03pm
ananthaps @ananthaps
@PATTL $CNAT is a dead story now. Vikings raise again.
March 21st 2019, 4:03pm
Roka_Dura @Roka_Dura
Watching $CNAT for bounce. Added to my watch list
March 21st 2019, 4:03pm
StockNewsNow @StockNewsNow
$CNAT Conatus Announces Top-line Results from ENCORE-NF Phase 2b Clinical Trial in NASH Fibrosis https://t.co/Obv0xUOyjq
March 21st 2019, 4:03pm
OptionsGunner1 @OptionsGunner1
Folks when Pfizer dumps a molecule and no one reputable picks it up usually it’s a sign said molecule has zero and I mean zero future $CNAT
March 21st 2019, 4:03pm
bs2537 @bs2537
Someone on Seeking Alpha has been pumping $CNAT tirelessly. How's it going out there..... down 50%. I told them to stay away... no position.
March 21st 2019, 4:03pm
EliteDayTraders @EliteDayTraders
reshorted $cnat 1.55 cov 1.39 +.16 w/2k shares live in chat what a day all live at https://t.co/KjuOQXm0JD https://t.co/yIgWkyzW12
March 21st 2019, 4:03pm
Wavyslime @Wavyslime
$cnat RIP
March 21st 2019, 4:03pm
jsksrs @jsksrs
Ok re $CNAT: I love the mgmt, they are cool guys and not your usual biotech crooks (I have a lot on my list). They… https://t.co/oKApT9DGfm
March 21st 2019, 4:03pm
LifeSciAdvisors @LifeSciAdvisors
Conatus $CNAT Announces Top-line Results from ENCORE-NF Phase 2b Clinical Trial in NASH Fibrosis https://t.co/wIsIAJECSW
March 21st 2019, 4:03pm
PipsToDollars @PipsToDollars
$CNAT -48% now on the day and they have options
March 21st 2019, 4:03pm
biostockinfo @biostockinfo
RT @BioRunUp: $CNAT 1.50 prints from a $2.91 close on ENCORE-NF #Fail
March 21st 2019, 4:03pm
JohnLBair1 @JohnLBair1
$CNAT missed primary #EndPoint https://t.co/09BGctgTL9
March 21st 2019, 4:03pm
stocktrader8000 @stocktrader8000
$CNAT Time to buy this!
March 21st 2019, 4:03pm
JohnLBair1 @JohnLBair1
$CNAT https://t.co/JUmRVssDNz
March 21st 2019, 4:03pm
VM1409 @VM1409
RT @TraderTexMex: $CNAT Shortfall on Primary Endpoint Shifts Focus for Emricasan to Ongoing NASH Cirrhosis Trials
March 21st 2019, 4:03pm
EliteDayTraders @EliteDayTraders
$CNAT this pr is a disaster, ceo tries to sugarcoat it but this is horrible news
March 21st 2019, 4:03pm
Stock_News_Now @Stock_News_Now
$CNAT: New SEC Filing for CNAT: Form 8-K (No. 0001171843-19-001889): https://t.co/xtAhimK828
March 21st 2019, 4:03pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.